COLLEYVILLE, TX--(Marketwire - September 9, 2008) - digiMedical Solutions, Inc. (PINKSHEETS: DGMS) announced today that the Company has signed a contract with Dr. Thomas Magardino of Collier Otolaryngology in Naples, Florida to implement the Company's proprietary .Net-based digital prescription handling software, digiRX and digiReauth, and to supply call center services to support the reauthorization of prescriptions. digiMedical's prescription handling software, digiRX, assists physicians in reducing fulfillment errors and alleviating prescription fraud concerns while the Company's prescription refill service allows patients to refill prescriptions while speaking with a live person instead of a confusing and often frustrating automated system.

Dr. Magardino, who sees on average 35-40 patients a day, has been in practice for 14 years. Dr. Magardino graduated from New York University School of Medicine and completed his residency at the University of Pennsylvania.

Earlier this year, digiMedical announced efforts to expand the Company's sales in Florida by signing contracts with doctors and clinics to implement the Company's proprietary digital prescription software and reauthorization call center services. Since launching those efforts, they have signed contracts with multiple doctors in Florida to include: Dr. Steven Bello of Collier Otolaryngology, Dr. Richard Wilson, Drs. Angela Marshall, Wendy Humphrey and Betsy Brothers of Southwest Florida Women's Group, P.A., Dr. Daniel Kaplan, Dr. Moorthy of Pain Management Center of Naples, Dr. Shardul Nanavati, founder of Advanced Gastroenterology, Drs. Romero, Tineo and Seibert of Oaktree Family Practice, Orthopedic Surgeon Dr. Howard Kapp of Anchor Health Centers, Drs. Santos-Ocampo, Axline and Spilker of the Collier Heart Group, Dr. John Landi, the Medical Director of Vanish Vein and Laser Center and Dr. Wey of the Neuroscience and Spine Associates in Naples, Florida, among others.

digiMedical's Prescription Handling Software

digiMedical has built a suite of proprietary software to digitally manage prescriptions in both doctor and clinic offices and in pharmacies. The digital prescriptions are routed directly and securely from the physician's office or clinic to the pharmacy. The digital pack of information also already contains pertinent patient information, allowing the pharmacy to pre-fill the prescription prior to the patient's arrival at the pharmacy.

The Company's digital prescription software suite meets HIPAA and DEA requirements and helps protect the pharmacist from errors caused by difficult-to-read handwritten prescriptions and the risk to the pharmacist of illegally duplicated prescriptions and fraudulent prescriptions. Additionally, digiMedical manages prescription refills for physicians' offices and clinics through the Company's digiReauth software and call center services. The suite of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and digiAccounting.

Company Updates and Information

digiMedical's software, which is currently in use in pharmacies in Naples and Ft. Meyers, Florida, and in Dallas, Texas, is now available for implementation nationwide in independent and chain pharmacies. If you are interested in learning more about digiMedical's software, or implementing the Company's proprietary technology in your pharmacy, please contact the Company at or 1-877-450-8181.

To be added to digiMedical's corporate e-mail list for shareholders and interested investors or to request additional information about the Company, please send an e-mail to

About digiMedical Solutions, Inc.™

digiMedical Solutions, Inc.™ ( is a pharmacy and medical technology company focused on developing next generation digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that will more closely align the doctor, pharmacist and patient. The Company's digital prescription handling software captures and transmits prescriptions digitally from the physician's office to the pharmacy, securely and in compliance with all DEA and HIPAA requirements. The suite of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and digiAccounting.

Forward-Looking Statement

Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission for additional information and a presentation of the risks and uncertainties that may affect the company's business and results of operations.

Contact Information: Contact: digiMedical Solutions, Inc. Investor Relations 214-722-3029 Sales: 1-877-450-8181